RBC Capital Maintains Outperform on Verastem, Lowers Price Target to $18
Benzinga Newsdesk 3 hours ago
Analyst RatingsNewsPrice Target
RBC Capital analyst Leonid Timashev maintains Verastem (NASDAQ:VSTM) with a Outperform and lowers the price target from $19 to $18.
RBC Capital analyst Leonid Timashev maintains Verastem (NASDAQ:VSTM) with a Outperform and lowers the price target from $19 to $18.